Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedJul 14, 2026
DataAggregated Company Financials
Companies13
- 7D2.9%
- 3M-15.8%
- 1Y-17.2%
- YTD-21.2%
Over the last 7 days, the Life Sciences industry has risen 2.9%, driven by gains from Shin Nippon Biomedical Laboratories of 7.8%. In the past year, the industry is down 17%. Looking forward, earnings are forecast to grow by 5.3% annually.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 15 Jul 2026 | JP¥114.9b | JP¥62.8b | JP¥631.5m | 24.1x | 182x | 1.8x |
| Fri, 12 Jun 2026 | JP¥104.0b | JP¥62.8b | JP¥599.2m | 22.2x | 173.6x | 1.7x |
| Sun, 10 May 2026 | JP¥140.3b | JP¥63.3b | -JP¥864,496,000.00 | 23.1x | -162.2x | 2.2x |
| Tue, 07 Apr 2026 | JP¥141.1b | JP¥63.3b | -JP¥864,496,000.00 | 21.2x | -163.2x | 2.2x |
| Thu, 05 Mar 2026 | JP¥140.7b | JP¥63.2b | -JP¥944,048,000.00 | 21.7x | -149.1x | 2.2x |
| Sat, 31 Jan 2026 | JP¥150.2b | JP¥66.9b | JP¥72.2m | 24.4x | 2080.8x | 2.2x |
| Mon, 29 Dec 2025 | JP¥151.2b | JP¥66.9b | JP¥72.2m | 21.3x | 2094.5x | 2.3x |
| Wed, 26 Nov 2025 | JP¥152.9b | JP¥67.3b | JP¥574.9m | 17.8x | 266x | 2.3x |
| Fri, 24 Oct 2025 | JP¥138.1b | JP¥66.5b | JP¥1.5b | 16.1x | 94.6x | 2.1x |
| Sun, 21 Sep 2025 | JP¥147.3b | JP¥66.5b | JP¥1.5b | 16.5x | 101x | 2.2x |
| Tue, 19 Aug 2025 | JP¥147.6b | JP¥66.5b | JP¥1.5b | 17.3x | 101.2x | 2.2x |
| Thu, 17 Jul 2025 | JP¥137.7b | JP¥66.0b | JP¥1.1b | 16.2x | 122x | 2.1x |
| Sat, 14 Jun 2025 | JP¥140.0b | JP¥66.0b | JP¥1.1b | 17x | 123.5x | 2.1x |
| Mon, 12 May 2025 | JP¥135.5b | JP¥65.9b | JP¥1.4b | 14.7x | 95.6x | 2.1x |
| Wed, 09 Apr 2025 | JP¥130.7b | JP¥63.8b | JP¥963.0m | 13.2x | 135.8x | 2x |
| Fri, 07 Mar 2025 | JP¥155.4b | JP¥65.1b | JP¥1.1b | 15.2x | 139.3x | 2.4x |
| Sun, 02 Feb 2025 | JP¥167.1b | JP¥62.0b | JP¥440.7m | 18.2x | 379.2x | 2.7x |
| Tue, 31 Dec 2024 | JP¥165.1b | JP¥62.0b | JP¥440.7m | 17.8x | 374.7x | 2.7x |
| Thu, 28 Nov 2024 | JP¥166.0b | JP¥62.0b | JP¥825.9m | 16.6x | 201x | 2.7x |
| Sat, 26 Oct 2024 | JP¥146.3b | JP¥61.5b | JP¥1.8b | 20.2x | 79.5x | 2.4x |
| Mon, 23 Sep 2024 | JP¥157.3b | JP¥61.5b | JP¥1.8b | 18.3x | 85.5x | 2.6x |
| Wed, 21 Aug 2024 | JP¥161.4b | JP¥61.7b | JP¥2.4b | 19.6x | 66.2x | 2.6x |
| Fri, 19 Jul 2024 | JP¥169.8b | JP¥61.8b | JP¥3.2b | 27.4x | 52.5x | 2.8x |
| Sun, 16 Jun 2024 | JP¥163.9b | JP¥61.8b | JP¥3.3b | 26.2x | 50.1x | 2.7x |
| Tue, 14 May 2024 | JP¥175.3b | JP¥62.0b | JP¥3.1b | 13.8x | 56.2x | 2.8x |
| Thu, 11 Apr 2024 | JP¥183.4b | JP¥62.3b | JP¥3.3b | 14.3x | 55.7x | 2.9x |
| Sat, 09 Mar 2024 | JP¥238.7b | JP¥155.3b | JP¥8.7b | 14x | 27.5x | 1.5x |
| Mon, 05 Feb 2024 | JP¥227.0b | JP¥155.5b | JP¥7.5b | 14.8x | 30.3x | 1.5x |
| Wed, 03 Jan 2024 | JP¥224.9b | JP¥167.1b | JP¥8.5b | 15x | 26.5x | 1.3x |
| Fri, 01 Dec 2023 | JP¥235.2b | JP¥167.4b | JP¥8.7b | 14.9x | 27.1x | 1.4x |
| Sun, 29 Oct 2023 | JP¥226.1b | JP¥179.3b | JP¥12.8b | 14.2x | 17.7x | 1.3x |
| Tue, 26 Sep 2023 | JP¥251.6b | JP¥179.3b | JP¥12.8b | 15.3x | 19.7x | 1.4x |
| Thu, 24 Aug 2023 | JP¥263.3b | JP¥179.3b | JP¥12.8b | 16.2x | 20.6x | 1.5x |
| Sat, 22 Jul 2023 | JP¥270.9b | JP¥178.7b | JP¥15.7b | 16.3x | 17.3x | 1.5x |
Price to Earnings Ratio
17.3x
Current Industry PE
- Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 182x which is higher than its 3-year average PE of 178x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 66% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -2.63% | |
| Healthcare | -3.01% | |
| Life Sciences | 2.85% | |
| Clinical Research and Equipment | 2.85% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.31k | 8.1% +JP¥4.1b | -4.4% | PE11.9x | |
| 4880 CellSource | JP¥349.00 | 6.1% +JP¥396.9m | -48.3% | PE99x | |
| 7707 Precision System Science | JP¥206.00 | 6.2% +JP¥329.5m | 5.6% | PE42.2x | |
| 7079 WDB coco | JP¥2.60k | 1.3% +JP¥81.8m | -10.8% | PE9.2x | |
| 4570 Immuno-Biological Laboratories | JP¥989.00 | 0.2% +JP¥18.6m | 101.0% | PE28x |